Select Page

M.chimaera in cardiothoracic heater cooler units – FDA moves to halt shipping from device manufacturer linked to patient deaths

Home Forums Infexion Connexion M.chimaera in cardiothoracic heater cooler units – FDA moves to halt shipping from device manufacturer linked to patient deaths

 | Click to Receive Email Notifications of Posts
  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #72658
    Glenys Harrington
    Participant

    Author:
    Glenys Harrington

    Position:
    Consultant

    Organisation:
    Infection Control Consultancy (ICC)

    State:

    Dear All,

    For those following the issue of cardiothoracic heater cooler units this
    article from Beckers Infection Control & Clinical Quality and FDA warning
    letter (following inspection at manufacturing plants) may be of interest.

    “FDA moves to halt shipping from device manufacturer linked to patient
    deaths

    The Food and Drug Administration
    has issued a warning letter to LivaNova, a London-based medical device
    manufacturer, stating the company does not provide adequate cleaning
    information to prevent bacteria from accumulating inside its heater-cooler
    machines, which were linked to deaths at
    WellSpan York (Pa.) Hospital in October and
    Penn State Hershey Medical Center in November. Between the two
    hospitals, 3,600 patients were notified that they may be at risk from
    infections due to the devices.

    The heater-cooler devices, used during open heart surgery to regulate
    temperature, never come into contact with patients. However, the machines
    are at risk of accumulating biofilm, which contains harmful bacteria that
    can be transmitted to patients through the air during surgery. Between Penn
    State Hershey Medical Center and WellSpan York Hospital, at least six deaths
    have been linked to the devices. In addition to finding the
    manufacturer-issued device-cleaning protocol to be ineffective, the FDA’s
    investigation revealed the devices were misbranded and the company was
    operating without an approved application for pre-market approval”.

    Beckers Infection Control & Clinical Quality – Written by Max Green |
    January 06, 2016

    http://www.beckershospitalreview.com/quality/fda-to-halts-shipping-from-devi
    ce-manufacturer-linked-to-4-deaths.html

    FDA Warning Letter

    http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm479684.ht
    m

    LivaNova PLC Provides Update on FDA Warning Letter – LONDON, Jan. 05, 2016

    http://www.livanova.com/investor-relations/pressreleases/news_release_212642
    9

    Regards

    Glenys

    Glenys Harrington

    Consultant

    Infection Control Consultancy (ICC)

    PO Box 5202

    Middle Park

    Victoria, 3206

    Australia

    M: +61 404 816 434

    infexion@ozemail.com.au

    ABN 47533508426

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 1 post (of 1 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.